About Ansell (ASX: ANN)
Ansell Limited designs, develops, manufactures, and distributes hand and body protection solutions across the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. The company operates through two segments, Healthcare and Industrial, serving a broad range of end markets from hospitals and surgical centres to chemical plants, mining operations, and food processing facilities.
The Healthcare segment covers surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments for customers including hospitals, dental surgeries, veterinary clinics, laboratories, and life sciences and pharmaceutical companies. The Industrial segment focuses on hand and chemical protective clothing for applications spanning automotive, metal fabrication, construction, oil and gas, utilities, and logistics. Products are sold under a portfolio of brands including ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING, among others. Formerly known as Pacific Dunlop Limited, the company adopted the Ansell name in 2002 and traces its origins to its founding in 1893. Ansell is headquartered in Richmond, Australia.
MFAM Research
- [BUY] Ansell (ASX ANN) is a Personal Protective Equipment Manufacturer and a Great Pandemic HedgeOctober 28, 2020Today, we’ll look at why we like Ansell shares (ASX ANN). Ansell specialises in manufacturing and distributing personal protective equipment (PPE). we first recommended Ansell back in April during the COVID crash and we take a deeper dive into the stock today. If the world is to learn from its COVID mistakes, PPE will become […]
Latest Announcements
- Ansell (ASX: ANN) – Ansell FY26 Full Year Results PresentationAugust 24, 2026Can you share the full financial results from the Ansell announcement? I only have the disclaimer and agenda page. I need the actual revenue, EBITDA, EPS, segment performance, and guidance figures to write the analyst commentary. Alternatively, if you have the complete PDF, I can fetch it directly. Do you have a URL to the […]
- Ansell (ASX: ANN) – FY26 Full Year Results and BuybackAugust 24, 2026Ansell Limited has delivered adjusted earnings per share of US148.6¢ for the full year ended 30 June 2026, landing in the upper half of the company’s guidance range. This represents growth of 17.8% on an organic constant currency basis from the prior year’s US126.1¢, demonstrating the company’s ability to drive earnings expansion through higher sales […]
- Ansell (ASX: ANN) – Files 2026 Full Year ReportAugust 24, 2026Ansell Limited delivered a substantial turnaround in profitability for FY26, with operating profit after tax doubling to US$208.6 million, representing 105.3% growth on the prior year. This significant earnings expansion comes against a more modest revenue backdrop, with sales reaching US$2,140.2 million, up 6.8% from the previous corresponding period. The divergence between top-line and bottom-line […]
Financial Summary
Price History
Related Stocks
| Same Industry — Healthcare | Same Sub-Industry — Medical Instruments & Supplies |
|---|---|